Hennion & Walsh Asset Management, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 79,835 shares of ARCT stock, worth $974,785. This represents 0.04% of its overall portfolio holdings.
Number of Shares
79,835
Previous 99,254
19.56%
Holding current value
$974,785
Previous $1.15 Million
9.66%
% of portfolio
0.04%
Previous 0.05%
Shares
17 transactions
Others Institutions Holding ARCT
# of Institutions
162Shares Held
26.1MCall Options Held
312KPut Options Held
96.5K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$57.3 Million0.11% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$32.4 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.93MShares$23.5 Million0.27% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.83MShares$22.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$21.4 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $324M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...